fda approved tirzepatide Day 4: Zepbound (Tirzepatide – weight loss indication) Approved: November 2023 for weight management Weight Loss: Up to 22.5% in clinical trials Similar to Mounjaro, but marketed specifically for weight management Tirzepatide Wins FDA Approval for

Why tirzepatide requires titration You can't start at full dose

Klinics weight loss treatments might be ideal for adults in Stockbridge, Georgia, who are overweight or living with obesity, particularly when paired with related health issues like high blood pressure or diabetes

If tirzepatide is discontinued, some or all of the lost weight may be regained, given how the medication works to regulate appetite and glucose metabolism

Zepbound injection resources If you need additional resources on how to inject Zepbound: View instructional videos on the manufacturers website (pen and syringe)

The net effect on any individual patient depends on the balance between potential adverse effects and the benefits of weight reduction